HFXI vs SBIO
NYLI FTSE International Equity Currency Neutral ETF vs ALPS Medical Breakthroughs ETF
Quick Verdict
HFXI has a lower expense ratio. SBIO delivered stronger 1-year returns. HFXI offers more diversification with 876 holdings.
Side-by-Side Comparison
| Metric | HFXI | SBIO | Winner |
|---|---|---|---|
| Expense Ratio | 0.20% | 0.50% | |
| AUM | $2.1B | $221M | |
| Dividend Yield | 3.39% | 0.00% | |
| Holdings | 876 | 107 | |
| YTD Return | +17.30% | +37.78% | |
| 1Y Return | +29.54% | +100.50% | |
| 3Y Return (annualized) | +21.69% | +34.22% | |
| 5Y Return (annualized) | +12.45% | +9.90% | |
| Volatility (annualized) | 13.8% | 29.6% | |
| Max Drawdown | -34.2% | -63.1% | |
| Fund Family | INDEXIQ ETF TRUST | ALPS Advisors | |
| Category | Equity | Equity | |
| Inception | Jul 22, 2015 | Dec 30, 2014 |
HFXI vs SBIO Performance
NYLI FTSE International Equity Currency Neutral ETF (HFXI) is a ETF from INDEXIQ ETF TRUST and ALPS Medical Breakthroughs ETF (SBIO) is a ETF from ALPS Advisors. Over the past year HFXI returned +29.54% while SBIO returned +100.50%. Year to date, HFXI is up 17.30% versus a gain of 37.78% for SBIO.
Over three years, HFXI compounded at +21.69% per year against +34.22% for SBIO; over five years the annualized figures are +12.45% and +9.90% respectively. Across the full 11-year window we track, SBIO has the edge at +9.97% annualized vs +7.92%. Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
SBIO has been the more volatile fund, with annualized monthly volatility of 29.6% compared with 13.8% for HFXI. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -34.2% for HFXI and -63.1% for SBIO. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.
The two funds' monthly returns correlate at 0.51. They move independently enough that combining them can meaningfully diversify a portfolio.
Fees and Cost Over Time
HFXI charges 0.20% per year while SBIO charges 0.50%. On a $10,000 position that is $20 vs $50 annually, a gap of $30 per year that compounds over a long holding period. On income, HFXI currently yields 3.39% against 0.00% for SBIO.
Holdings Overlap
HFXI and SBIO share 2 holdings out of 845 unique holdings combined, representing a 0.0% weight overlap.
Moderate overlap means holding both could provide meaningful diversification benefits.
Frequently Asked Questions
Which is cheaper, HFXI or SBIO?
HFXI has an expense ratio of 0.20% while SBIO charges 0.50%. HFXI is the cheaper option. On a $10,000 investment, that is $30 per year of difference.
Which performed better, HFXI or SBIO?
Over the past year HFXI returned +29.54% vs +100.50% for SBIO, so SBIO leads on 1-year performance. Over the longest common window we track (11 years), HFXI annualized +7.92% vs +9.97% for SBIO. Past performance does not guarantee future results.
Which is riskier, HFXI or SBIO?
SBIO has been the more volatile fund at 29.6% annualized versus 13.8% for HFXI. Worst drawdown: HFXI -34.2% vs SBIO -63.1%.
Should I hold both HFXI and SBIO?
HFXI and SBIO have a monthly-return correlation of 0.51, so combining them can provide real diversification depending on your allocation goals.
What is the holdings overlap between HFXI and SBIO?
HFXI and SBIO share 2 common holdings with a 0.0% weight overlap. Combined, they hold 845 unique securities.
Which pays a higher dividend, HFXI or SBIO?
HFXI yields 3.39% while SBIO yields 0.00%, so HFXI currently pays the higher dividend yield.
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.